Brooks Laboratories Ltd
NSE:BROOKS

Watchlist Manager
Brooks Laboratories Ltd Logo
Brooks Laboratories Ltd
NSE:BROOKS
Watchlist
Price: 159.99 INR 2%
Market Cap: 4.2B INR
Have any thoughts about
Brooks Laboratories Ltd?
Write Note

Brooks Laboratories Ltd
Short-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Brooks Laboratories Ltd
Short-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
Brooks Laboratories Ltd
NSE:BROOKS
Short-Term Debt
â‚ą50.4m
CAGR 3-Years
-28%
CAGR 5-Years
-19%
CAGR 10-Years
43%
Divi's Laboratories Ltd
NSE:DIVISLAB
Short-Term Debt
â‚ą0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Suven Life Sciences Ltd
NSE:SUVEN
Short-Term Debt
â‚ą0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dishman Carbogen Amcis Ltd
NSE:DCAL
Short-Term Debt
â‚ą0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Syngene International Ltd
NSE:SYNGENE
Short-Term Debt
â‚ą0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
I
Innova Captab Ltd
NSE:INNOVACAP
Short-Term Debt
â‚ą238.4m
CAGR 3-Years
-11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Brooks Laboratories Ltd
Glance View

Market Cap
4.2B INR
Industry
Life Sciences Tools & Services

Brooks Laboratories Ltd. is a research and development driven pharmaceutical manufacturing company. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2011-09-02. The firm operates through the Pharmaceuticals segment. The company manufactures various pharmaceutical dosage forms, including injections, tablets, dry syrup and eye/ear drops. Its products under Carbapenem category includes Imipenem 250mg + Cilastatin 250mg, Imipenem 500mg + Cilastatin 500mg, Meropenem 125mg, Meropenem 250mg, Meropenem 500mg, Meropenem 1000mg, Meropenem 1000mg+Sulbactam 500mg, Meropenem 1000mg+Tazobactam 500mg, Doripenem 500mg and Doripenem 1000mg. The company offers Penicillins in the form of injections, tablets and dry syrup. Its General category of products include liquid injections, dry powder injections and eye/ear drops. The firm has two manufacturing plants, which are located at Baddi in Himachal Pradesh and Vadodara in Gujarat. The firm manufactures and markets the pharmaceuticals nationally and internationally to various regulated markets.

BROOKS Intrinsic Value
45.27 INR
Overvaluation 72%
Intrinsic Value
Price

See Also

What is Brooks Laboratories Ltd's Short-Term Debt?
Short-Term Debt
50.4m INR

Based on the financial report for Jun 30, 2024, Brooks Laboratories Ltd's Short-Term Debt amounts to 50.4m INR.

What is Brooks Laboratories Ltd's Short-Term Debt growth rate?
Short-Term Debt CAGR 10Y
43%

The average annual Short-Term Debt growth rates for Brooks Laboratories Ltd have been -28% over the past three years , -19% over the past five years , and 43% over the past ten years .

Back to Top